You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

interleukin-2

Showing 1 - 25 of 110
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer Trial in Houston (Interleukin-2, Placebo)

Recruiting
  • Alzheimer Disease
  • Interleukin-2
  • Placebo
  • Houston, Texas
    Houston Methodist Research Institute
Oct 17, 2023

Dermatomyositis Trial (Interleukin-2)

Not yet recruiting
  • Dermatomyositis
  • Interleukin-2
  • (no location specified)
Aug 8, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in

Not yet recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Biospecimen Collection
  • +8 more
  • Kansas City, Kansas
    University of Kansas Cancer Center
Nov 27, 2023

Kidney Cancer Trial in Tampa (Pembrolizumab, Interleukin-2)

Active, not recruiting
Has Results
  • Kidney Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 21, 2022

Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))

Completed
  • Pleural Mesothelioma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)

Recruiting
  • Neuroblastoma Recurrent
  • Natural killer cell
  • +4 more
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Feb 22, 2023

Renal Cell Carcinoma Trial in United States (Entinostat, Interleukin-2)

Active, not recruiting
  • Renal Cell Carcinoma
  • Los Angeles, California
  • +4 more
Feb 14, 2022

Systemic Lupus Erythematosus, Lupus Nephritis Trial in Nanjing (Human umbilical cord mesenchymal stem cells, Interleukin-2)

Recruiting
  • Systemic Lupus Erythematosus
  • Lupus Nephritis
  • Human umbilical cord mesenchymal stem cells
  • Interleukin-2
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Nov 20, 2022

Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2)

Not yet recruiting
  • Uveal Melanoma
  • Metastatic Cutaneous Melanoma
  • Autologous Tumor Infiltrating Lymphocytes
  • +2 more
  • (no location specified)
Jun 5, 2023

Melanoma Stage III, Melanoma Stage IV, Inoperable Disease Trial in Tampa (Interleukin-2, Ipilimumab, Nivolumab)

Recruiting
  • Melanoma Stage III
  • +2 more
  • Interleukin-2
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 6, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Cytokine-Induced Memory-like Natural Killer Cells
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 22, 2023

Breast Tumors Trial in Guangzhou (procedure, drug, biological)

Recruiting
  • Breast Neoplasms
  • Sentinel Lymph Node Biopsy (SLNB)
  • +7 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 2, 2023

HIV Trial run by the NIAID (Interleukin-2)

Completed
  • HIV Infections
  • Interleukin-2
  • Bethesda, Maryland
    NIH Intramural Research Program ACTG CRS
Oct 28, 2021

NHL, Multiple Myeloma, Blood Cancer Trial in Minneapolis, Houston, Fairfax (IDP-023, Rituximab, Daratumumab)

Recruiting
  • NHL
  • +6 more
  • Minneapolis, Minnesota
  • +2 more
Nov 7, 2023

Breast Tumors Trial in Guangzhou (procedure, drug, biological)

Recruiting
  • Breast Neoplasms
  • Surgery for harvesting tumor-draining lymph nodes
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 2, 2023

Solid Tumor Trial in Wuhan (HPV-T, Interleukin-2)

Recruiting
  • Solid Tumor
  • HPV-T
  • Interleukin-2
  • Wuhan, Hubei, China
    Wuhan Union Hospital
May 31, 2023

Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)

Recruiting
  • Metastatic Melanoma
  • +9 more
  • TBio-4101
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 24, 2023

Breast Tumors Trial in Guangzhou (procedure, drug, biological)

Recruiting
  • Breast Neoplasms
  • Sentinel Lymph Node Biopsy (SLNB)
  • +7 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 31, 2023

Breast Tumors Trial in Guangzhou (procedure, drug, biological)

Recruiting
  • Breast Neoplasms
  • Surgery for harvesting tumor-draining lymph nodes
  • +8 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 31, 2023

Relapsed or Refractory Hodgkin Lymphoma, Peripheral T Cell Lymphoma Trial (AFM13, AB-101, Cyclophosphamide)

Not yet recruiting
  • Relapsed or Refractory Hodgkin Lymphoma
  • Peripheral T Cell Lymphoma
  • (no location specified)
May 30, 2023

Solid Tumor, Adult Trial in Lausanne (biological, drug, radiation)

Recruiting
  • Solid Tumor, Adult
  • NeoTIL
  • +4 more
  • Lausanne, Vaud, Switzerland
    centre hospitalier universitaire vaudois (CHUV)
Jun 23, 2022

Solid Tumor Trial in Wuhan (Neo-T, Cyclophosphamide, Fludarabine)

Recruiting
  • Solid Tumor
  • Neo-T
  • +3 more
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Mar 23, 2023

Solid Tumor Trial in Shanghai (Neo-T, Cyclophosphamide, Fludarabine)

Recruiting
  • Solid Tumor
  • Neo-T
  • +3 more
  • Shanghai, China
  • +1 more
Mar 23, 2023

Metastatic Melanoma Trial in Lausanne (TIL, Cyclophosphamide, Fludarabine)

Active, not recruiting
  • Metastatic Melanoma
  • TIL
  • +4 more
  • Lausanne, Vaud, Switzerland
    CHUV Oncology Department
Oct 11, 2021

B-Cell Leukemia, B-Cell Lymphoma Trial in Guangzhou (4SCAR19/22 T cells, Interleukin-2)

Suspended
  • B-Cell Leukemia
  • B-Cell Lymphoma
  • 4SCAR19/22 T cells
  • Interleukin-2
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Aug 9, 2021